Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Liabilities and Shareholders Equity: 2021-2025

Historic Liabilities and Shareholders Equity for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $5.4 billion.

  • Roivant Sciences' Liabilities and Shareholders Equity fell 18.42% to $5.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $21.3 billion, marking a year-over-year decrease of 21.71%. This contributed to the annual value of $5.4 billion for FY2025, which is 24.72% down from last year.
  • According to the latest figures from FY2025, Roivant Sciences' Liabilities and Shareholders Equity is $5.4 billion, which was down 6.14% from $5.8 billion recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Liabilities and Shareholders Equity registered a high of $7.3 billion during FY2023, and its lowest value of $2.2 billion during FY2022.
  • For the 3-year period, Roivant Sciences' Liabilities and Shareholders Equity averaged around $5.6 billion, with its median value being $5.8 billion (2024).
  • In the last 5 years, Roivant Sciences' Liabilities and Shareholders Equity skyrocketed by 231.95% in 2023 and then fell by 24.72% in 2025.
  • Yearly analysis of 5 years shows Roivant Sciences' Liabilities and Shareholders Equity stood at $2.6 billion in 2021, then reached $2.8 billion in 2021, then decreased by 0.18% to $2.6 billion in 2022, then decreased by 21.31% to $2.2 billion in 2022, then dropped by 7.56% to $2.4 billion in 2023, then spiked by 231.95% to $7.3 billion in 2023, then soared by 202.25% to $7.2 billion in 2024, then decreased by 20.79% to $5.8 billion in 2024, then decreased by 24.72% to $5.4 billion in 2025.